NCT02041260 · Interventional trial
A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Overall registry status Unknown
Phase 2
Conditions Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory